Wells Fargo
DRUG

Wells Fargo’s Bright Minds Biosciences DRUG Stock Holding History

Wells Fargo’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$185K Sell
2,532
-2,991
-54% -$241K ﹤0.01% 4748
2025
Q4 		$431K Buy
5,523
+2,697
+95% +$180K ﹤0.01% 4600
2025
Q3 		$171K Buy
2,826
+448
+19% +$17.4K ﹤0.01% 5011
2025
Q2 		$62.1K Buy
+2,378
New +$71.3K ﹤0.01% 5436

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Wells Fargo's DRUG Position: Q1 2026 in Review

Wells Fargo reduced its Bright Minds Biosciences (DRUG) stake by 54% in Q1 2026, selling an estimated $241K and leaving 2,532 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #4748.

Wells Fargo first reported a position in DRUG in Q2 2025 and has held it in 4 quarters since. The position peaked at $431K in Q4 2025. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Wells Fargo held 2,532 shares of Bright Minds Biosciences worth $185K as of Q1 2026.
  • Wells Fargo sold 2,991 Bright Minds Biosciences shares in Q1 2026, an estimated $241K.
  • Bright Minds Biosciences made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4748 holding.
  • Wells Fargo first reported a position in Bright Minds Biosciences in Q2 2025 and has held it in 4 quarters since.
  • Wells Fargo's Bright Minds Biosciences position peaked at $431K in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.